RaQualia Pharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 126.11% vs 81.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 642.94% vs 24.71% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,668.90",
          "val2": "738.10",
          "chgp": "126.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "958.50",
          "val2": "-64.80",
          "chgp": "1,579.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.60",
          "val2": "14.00",
          "chgp": "4.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.50",
          "val2": "-27.00",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "842.10",
          "val2": "-155.10",
          "chgp": "642.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "496.40%",
          "val2": "-252.20%",
          "chgp": "74.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,980.00",
          "val2": "3,107.60",
          "chgp": "28.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "971.90",
          "val2": "188.30",
          "chgp": "416.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "61.10",
          "val2": "184.10",
          "chgp": "-66.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "26.20",
          "val2": "-23.50",
          "chgp": "211.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "273.10",
          "val2": "-495.00",
          "chgp": "155.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.50%",
          "val2": "-68.70%",
          "chgp": "19.02%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

1,668.90

738.10

126.11%

Operating Profit (PBDIT) excl Other Income

958.50

-64.80

1,579.17%

Interest

14.60

14.00

4.29%

Exceptional Items

-4.50

-27.00

83.33%

Consolidate Net Profit

842.10

-155.10

642.94%

Operating Profit Margin (Excl OI)

496.40%

-252.20%

74.86%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 126.11% vs 81.93% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 642.94% vs 24.71% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,980.00

3,107.60

28.07%

Operating Profit (PBDIT) excl Other Income

971.90

188.30

416.14%

Interest

61.10

184.10

-66.81%

Exceptional Items

26.20

-23.50

211.49%

Consolidate Net Profit

273.10

-495.00

155.17%

Operating Profit Margin (Excl OI)

121.50%

-68.70%

19.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 28.07% vs 63.45% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 155.17% vs -52.92% in Dec 2024

All Annual Results